Skip to content

The RSV GOLD III study

Global Pediatric real-time RSV-related Illness at Intensive Care Units - The RSV GOLD III study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24263
Enrollment
4000
Registered
2021-05-27
Start date
2020-11-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory syncytial virus and Influenza virus

Interventions

POC RSV test and 2 questionnaires

Sponsors

UMC Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For this study, 2 groups (A and B) are distinguished: • Group A: Suspected RSV (10 study sites): Children under 2 years of age admitted to an ICU or HDU who meet the WHO case definition “extended SARI”. All children will be tested for RSV. At 3 study sites, children from group A will also be tested for influenza. • Group B: Non-suspected RSV (3 study sites; 1 site per country): To determine whether the case definition “extended SARI” is sufficiently sensitive for detecting children with severe RSV infection, we will also test children for RSV who do not meet the case definition at 3 study sites: children under 2 years of age admitted to an ICU or HDU who do not meet the WHO case definition “extended SARI”.

Exclusion criteria

Exclusion criteria: Subjects can only participate when RSV or influenza samples are collected while admitted to the ICU or HDU at participating study sites. Subjects <4 days of age will be excluded.

Design outcomes

Primary

MeasureTime frame
To describe the clinical, demographic and socioeconomic characteristics of RSV-positive children under 2 years of age who have been admitted with suspected RSV infection at ICUs or HDUs in GAVI eligible countries.

Contacts

Public ContactYvette Löwensteyn

UMC Utrecht

y.n.loewensteyn@umcutrecht.nl0031611845371

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)